China Growth Opportunities Limited is registered in Guernsey,
is self managed, and is listed on the UK's AIM Stock Market
The Investing Policy of the Company is to manage the sale of the Company's investment portfolio, which consists of passive interests in businesses whose business operations are based in China, and to maximise the return of funds, via the return of capital, to shareholders during the period ending on 30 September 2012.
The Company will not employ gearing nor will it invest further funds in new of existing investments but is actively seeking to divest all investments held by 30 September 2012.
Rhys Davies (Executive Chairman)
Rhys is a General Partner of Damille Partners, which he established in October 2008 with Brett Miller (with each holding a 50% partnership interest).
Rhys is also an Executive Director of Damille Investments Limited and Damille Partners Limited. Rhys also presently serves as the Non-Executive Chairman of Rapid Realisations Limited, an AIM quoted Guernsey registered investment company, and EIH plc, an AIM quoted Isle of Man registered investment company.
Rhys holds degrees from the University of Wales, Cardiff, and Imperial College, London, as well as the CFA designation.
Brett Miller (Executive Director)
Brett is a General Partner of Damille Partners, which he established in October 2008 with Rhys Davies (with each holding a 50% partnership interest).
Brett is also an Executive Director of Damille Investments Limited and Damille Partners Limited. Brett also presently serves as Non-Executive Director of Rapid Realisations Limited, an AIM quoted Guernsey registered investment company, and EIH plc, an AIM quoted Isle of Man registered investment company.
Brett also serves as a Non-Executive Director of Pactolus Hungarian Property PLC, an AIM quoted property fund, as well as serving as the Non-Executive Chairman of Globo PLC, an AIM quoted IT services provider.
Brett graduated from the University of the Witwatersrand (South Africa) with a bachelors degree majoring in law and economics and additionally holds a law degree from the London School of Economics (after having relocated to the United Kingdom in 1988).
Weiming Zhang (Non - Executive Director)
Dr Zhang has over fifteen years of experience in the investment banking business in Asia with a focus on China. From 1994 to 1999, Dr Zhang worked in the corporate finance division of Merrill Lynch (Hong Kong) and later in the corporate finance division at Deutsche Morgan Grenfell (Hong Kong) as the Director responsible for coverage and execution of overseas IPOs. Dr Zhang returned to Shanghai in 2000 and became Managing Director of First Alliance Capital, whose clients include leading consumer goods, auto and manufacturing companies, power and energy companies.
Dr Zhang received her Ph.D. degree from Columbia Business School in New York, a Master of Science degree from the University of Kentucky and a Bachelor degree in Computer Science from Southwest University of China.
The Company is managed by the Board of Directors, which consists of two Executive and one Non-Executive Director.
Board Responsibilities
The responsibilities of the Board of Directors are set out below:
- Determination of the Company's Investing Policy and overall responsibility for the Company's activities including the review of investment activity and performance;
- Ensuring that commercial and regulatory risks and financing needs are properly considered and that the obligations of a public company are adhered to; and
- Implementing appropriate corporate governance standards and overseeing the effectiveness of the Company's system of internal control.
As part of the Company's internal control structure, the Board has set up an Audit Committee, Management Engagement Committee and a Nomination Committee. The committees comprise all of the Directors.
Investor Relations
AIM Rule 26
The following information is disclosed in accordance with Rule 26 of the AIM rules.
(Last updated: 20/10/2011)
Description of Business and Investing Policy
Please follow the link below for a description of the business.
About CGO
The names of the directors and biographical details
Please follow the link below for the names of the directors and brief biographical details of each.
Board of Directors
Directors' responsibilities and board committees
Please follow the link below for a description of Directors' responsibilities.
Board of Directors and their committees
Country of incorporation and main country of operation
The Company is a closed-ended investment company domiciled and incorporated as a limited liability company in Guernsey. As the Company is not incorporated in the UK, the rights of shareholders may be different from the rights of shareholders in a UK incorporated company. CGO's main country of operation is China.
Memorandum and Articles of Incorporation
Please follow the link below for the Memorandum and Articles of Incorporation.
Memorandum and Articles of Incorporation
Details of any other exchanges or trading platforms
The Company's ordinary shares (code: CGOP) and warrants (code: CGOW) are traded on AIM. The Company is not listed on any other exchanges or trading platforms.
Number of securities in issue
There are 50,000,000 ordinary shares and 10,000,000 warrants of the Company in issue.
Percentage of the Company's issued share capital that is not in public hands
In accordance with the AIM Rules (Rule 26), in so far as the Company is aware, the percentage of the Company's issued share capital that is not in public hands is 70.64%.
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
Company Shareholdings
The Company has been notified, in accordance with the Disclosure and Transparency Rules, of the following shareholdings amounting to 3% or more of the ordinary capital of the Company.
At 20 October 2011, the Company had received notification of the following substantial shareholders::
| Funds Managed By | Number of Shares | % of Issued Share Capital |
|---|---|---|
| Weiss Asset Management LP | 11,884,336 | 23.77% |
| Damille Partners II | 9,751,920 | 19.50% |
| QVT Financial | 9,369,796 | 18.74% |
| Newton Investment Management | 6,602,612 | 13.21% |
| Schroder Investment Management | 2,437,272 | 4.87% |
| SVM Asset Management | 2,000,000 | 4.00% |
Financial information
Please follow the link below for access to the Company's annual and half-yearly reports.
Reports
Company announcements
Please follow the link below to access notifications made by the Company in the past 12 months.
Regulatory News
Advisors
| Registrar | Administrator, Secretary and Registered Office |
|---|---|
|
Capita Registrars (Guernsey) Limited Longue Hougue House St Sampson Guernsey GY2 4JN |
Elysium Fund Management Limited 1st Floor Royal Chambers St Julian's Avenue St Peter Port Guernsey GY1 3JX Tel: +44 1481 810 100 Email: elysium@elysiumfundman.com |
| Nominated Adviser and Broker | Independent Auditors |
|
Singer Capital Markets Limited One Hanover Street London W1S 1YZ Tel: +44 20 3205 7500 Email: enquiries@singercm.com |
PricewaterhouseCoopers CI LLP Royal Bank Place 1 Glategny Esplanade St Peter Port Guernsey GY1 4ND |
| Guernsey Legal Adviser to the Company | English Legal Adviser to the Company |
|
Carey Olsen Carey House Les Banques St Peter Port Guernsey GY1 4BZ |
Stephenson Harwood 1 Finsbury Circus London EC2M 7SH |
| Custodian and Settlement Agent | |
|
Butterfield Bank (Guernsey) Limited PO Box 25 Regency Court Glategny Esplanade St Peter Port Guernsey GY1 3AP |
2011
Half Yearly Report and Financial Statements for the Period Ended 30 September 2011
Annual Report and Financial Statements for the Year Ended 31 March 2011
2010
Half-Yearly Report and Financial Statements for the Period Ended 30 September 2010
Annual Report and Financial Statements for the Year Ended 31 March 2010
2009
Half-Yearly Report and Financial Statements for the Period Ended 30 September 2009
Annual Report and Financial Statements for the Year Ended 31 March 2009
2008
Half-Yearly Report and Financial Statements for the Period Ended 30 September 2008
Annual Report and Financial Statements for the Year Ended 31 March 2008
2007
Half-Yearly Report and Financial Statements for the Period Ended 30 September 2007
Annual Report and Financial Statements for the Year Ended 31 March 2007
2006
Half-Yearly Report and Financial Statements for the Period Ended 30 September 2006
30/09/11
Half Yearly Results
23/09/11
AGM Statement
30/08/11
Change of Registered Office
04/08/11
Final Results
28/07/11
Return of Capital
08/06/11
Return of Capital
24/03/11
Update re China CDM
08/02/11
Final date for Warrant Exercise
20/01/11
Holding(s) in Company
17/01/11
Holding(s) in Company
17/01/11
Holding(s) in Company 2
17 01 11
Holding(s) in Company 3
17/01/11
Director PDMR Shareholding
13/01/11
Return of Capital and disposal
07/12/10
Half Yearly Report
16/11/10
Investment Update
05/11/10
Holding(s) in Company
08/10/10
Holding(s) in Company
14/09/10
Result of AGM
17/08/10
Annual Financial Report
10/08/10
Final Results
11/06/10
Holding(s) in Company
18/03/10
Holding(s) in Company
26/02/10
Holding(s) in Company
09/12/09
Half Yearly Results
05/11/09
Holding(s) in Company
06/11/09
Change of Nominated Adviser and Broker
22/10/09
Investment Policy Announcement
20/10/09
Resignation of Director
29/09/09
PLC Termination Announcement
16/09/09
Return of Capital
16/09/09
Result of AGM
16/09/09
AGM Announcement
28/08/09
Sale of China New Energy
07/08/09
Holding in Company
03/08/09
Holding in Company
14/07/09
Annual Report available
09/07/09
Annual Results
06/07/09
Result of EGM
29/06/09
Holding(s) in Company
10/06/09
Circular- Return on Capital
25/05/09
Holding(s) in Company
22/05/09
Holding(s) in Company
20/05/09
Holding(s) in Company
09/04/09
Appointment of New Non Executive Director
01/04/09
ACE, Biofoods, Hainan sale Announcement
22/03/09
Investment Support Termination
27/02/09
Full Year Financial Statement and Dividend Announcement
12/02/09
Portfolio Update- AWT, DBI and Biofoods
23/01/09
EGM Announcement- Directors Appointment
07/01/09
Portfolio Update- AWT
Contact Us
Elysium Fund Management Limited
PO Box 650
1st Floor Royal Chambers
St Julian's Avenue
St Peter Port
Guernsey
GY1 3JX
Tel: +44 1481 810 100
Email: elysium@elysiumfundman.com